Europe PMC requires Javascript to function effectively.

Either your web browser doesn't support Javascript or it is currently turned off. In the latter case, please turn on Javascript support in your web browser and reload this page.

Search life-sciences literature (45,100,050 articles, preprints and more)

Search results

1-22 of 22 results

Sort by:

Relevance ^{Relevance: This is determined based on a ranking of criteria including term frequency, rarity of term, recency of article, whether there is a Title or Author field match, etc.}

Times cited

Date

Fibroblast growth factor 21 is a hepatokine involved in MASLD progression.
Gallego-Durán R, Ampuero J, Maya-Miles D, Pastor-Ramírez H, Montero-Vallejo R, Rivera-Esteban J, Álvarez-Amor L, Pareja MJ, Rico MC, Millán R, Robles-Frías MJ, Aller R, Rojas Á, Muñoz-Hernández R, Gil-Gómez A, Gato S, García-Lozano M, Arias-Loste MT, Abad J, [...] Romero-Gómez M
United European Gastroenterol J, 12(8):1056-1068, 18 Jun 2024
Cited by: 2 articles | PMID: 38894596 | PMCID: PMC11485537
Add to export list
This article is in the Europe PMC Open access subset. Refer to the copyright information in the article for licensing details.
Free full text in Europe PMC
Serum ferritin levels can predict long-term outcomes in patients with metabolic dysfunction-associated steatotic liver disease.
Armandi A, Sanavia T, Younes R, Caviglia GP, Rosso C, Govaere O, Liguori A, Francione P, Gallego-Duràn R, Ampuero J, Pennisi G, Aller R, Tiniakos D, Burt A, David E, Vecchio F, Maggioni M, Cabibi D, McLeod D, [...] Bugianesi E
Gut, 73(5):825-834, 05 Apr 2024
Cited by: 3 articles | PMID: 38199805
Add to export list
miR-21-5p promotes NASH-related hepatocarcinogenesis.
Rodrigues PM, Afonso MB, Simão AL, Islam T, Gaspar MM, O'Rourke CJ, Lewinska M, Andersen JB, Arretxe E, Alonso C, Santos-Laso Á, Izquierdo-Sanchez L, Jimenez-Agüero R, Eizaguirre E, Bujanda L, Pareja MJ, Prip-Buus C, Banales JM, Rodrigues CMP, Castro RE
Liver Int, 43(10):2256-2274, 03 Aug 2023
Cited by: 7 articles | PMID: 37534739
Add to export list
Cost-Effectiveness of Next-Generation Sequencing Versus Single-Gene Testing for the Molecular Diagnosis of Patients With Metastatic Non-Small-Cell Lung Cancer From the Perspective of Spanish Reference Centers.
Arriola E, Bernabé R, Campelo RG, Biscuola M, Enguita AB, López-Ríos F, Martínez R, Mezquita L, Palanca S, Pareja MJ, Zugazagoitia J, Arrabal N, García JF, García JF, Carcedo D, de Álava E
JCO Precis Oncol, 7:e2200546, 01 Mar 2023
Cited by: 10 articles | PMID: 36862967 | PMCID: PMC10309530
Add to export list
This article is in the Europe PMC Open access subset. Refer to the copyright information in the article for licensing details.
Free full text in Europe PMC
Cost-effectiveness analysis of molecular diagnosis by next-generation sequencing versus sequential single testing in metastatic non-small cell lung cancer patients from a south Spanish hospital perspective.
de Alava E, Pareja MJ, Carcedo D, Arrabal N, García JF, Bernabé-Caro R
Expert Rev Pharmacoecon Outcomes Res, 22(6):1033-1042, 25 May 2022
Cited by: 6 articles | PMID: 35593180
Add to export list
Liver injury in non-alcoholic fatty liver disease is associated with urea cycle enzyme dysregulation.
Gallego-Durán R, Ampuero J, Pastor-Ramírez H, Álvarez-Amor L, Del Campo JA, Maya-Miles D, Montero-Vallejo R, Cárdenas-García A, Pareja MJ, Gato-Zambrano S, Millán R, Del Carmen Rico M, Luque-Sierra A, Gil-Gómez A, Rojas Á, Muñoz-Hernández R, García-Lozano M, Aller R, Andrade RJ, [...] Romero-Gómez M
Sci Rep, 12(1):3418, 01 Mar 2022
Cited by: 11 articles | PMID: 35232986 | PMCID: PMC8888708
Add to export list
This article is in the Europe PMC Open access subset. Refer to the copyright information in the article for licensing details.
Free full text in Europe PMC
The altered serum lipidome and its diagnostic potential for Non-Alcoholic Fatty Liver (NAFL)-associated hepatocellular carcinoma.
Lewinska M, Santos-Laso A, Arretxe E, Alonso C, Zhuravleva E, Jimenez-Agüero R, Eizaguirre E, Pareja MJ, Romero-Gómez M, Arrese M, Suppli MP, Knop FK, Oversoe SK, Villadsen GE, Decaens T, Carrilho FJ, de Oliveira CP, Sangro B, Macias RIR, [...] Andersen JB
EBioMedicine, 73:103661, 29 Oct 2021
Cited by: 22 articles | PMID: 34740106 | PMCID: PMC8577325
Add to export list
This article is in the Europe PMC Open access subset. Refer to the copyright information in the article for licensing details.
Free full text in Europe PMC
Implementing Personalized Medicine in COVID-19 in Andalusia: An Opportunity to Transform the Healthcare System.
Dopazo J, Maya-Miles D, García F, Lorusso N, Calleja MÁ, Pareja MJ, López-Miranda J, Rodríguez-Baño J, Padillo J, Túnez I, Romero-Gómez M
J Pers Med, 11(6):475, 26 May 2021
Cited by: 12 articles | PMID: 34073493 | PMCID: PMC8226500
Add to export list Review
This article is in the Europe PMC Open access subset. Refer to the copyright information in the article for licensing details.
Free full text in Europe PMC
Adiponectin, Leptin, and IGF-1 Are Useful Diagnostic and Stratification Biomarkers of NAFLD.
Marques V, Afonso MB, Bierig N, Duarte-Ramos F, Santos-Laso Á, Jimenez-Agüero R, Eizaguirre E, Bujanda L, Pareja MJ, Luís R, Costa A, Machado MV, Alonso C, Arretxe E, Alustiza JM, Krawczyk M, Lammert F, Tiniakos DG, Flehmig B, [...] Rodrigues CMP
Front Med (Lausanne), 8:683250, 23 Jun 2021
Cited by: 28 articles | PMID: 34249975 | PMCID: PMC8260936
Add to export list
This article is in the Europe PMC Open access subset. Refer to the copyright information in the article for licensing details.
Free full text in Europe PMC
Long-term outcomes and predictive ability of non-invasive scoring systems in patients with non-alcoholic fatty liver disease.
Younes R, Caviglia GP, Govaere O, Rosso C, Armandi A, Sanavia T, Pennisi G, Liguori A, Francione P, Gallego-Durán R, Ampuero J, Garcia Blanco MJ, Aller R, Tiniakos D, Burt A, David E, Vecchio FM, Maggioni M, Cabibi D, [...] Bugianesi E
J Hepatol, 75(4):786-794, 04 Jun 2021
Cited by: 68 articles | PMID: 34090928
Add to export list
Caucasian lean subjects with non-alcoholic fatty liver disease share long-term prognosis of non-lean: time for reappraisal of BMI-driven approach?
Younes R, Govaere O, Petta S, Miele L, Tiniakos D, Burt A, David E, Vecchio FM, Maggioni M, Cabibi D, McLeod D, Pareja MJ, Fracanzani AL, Aller R, Rosso C, Ampuero J, Gallego-Durán R, Armandi A, Caviglia GP, [...] Bugianesi E
Gut, 71(2):382-390, 04 Feb 2021
Cited by: 78 articles | PMID: 33541866
Add to export list
RIPK3 acts as a lipid metabolism regulator contributing to inflammation and carcinogenesis in non-alcoholic fatty liver disease.
Afonso MB, Rodrigues PM, Mateus-Pinheiro M, Simão AL, Gaspar MM, Majdi A, Arretxe E, Alonso C, Santos-Laso A, Jimenez-Agüero R, Eizaguirre E, Bujanda L, Pareja MJ, Banales JM, Ratziu V, Gautheron J, Castro RE, Rodrigues CMP
Gut, 70(12):2359-2372, 24 Dec 2020
Cited by: 43 articles | PMID: 33361348 | PMCID: PMC8588316
Add to export list
This article is in the Europe PMC Open access subset. Refer to the copyright information in the article for licensing details.
Free full text in Europe PMC
Alcohol-related liver disease. Clinical practice guidelines. Consensus document sponsored by AEEH.
Bataller R, Cabezas J, Aller R, Ventura-Cots M, Abad J, Albillos A, Altamirano J, Arias-Loste MT, Bañares R, Caballería J, Caballería L, Carrión JA, Diago M, Fernández Rodríguez C, Gallego R, García-Cortes M, García-Monzón C, Genescà J, Ginés P, [...] Romero-Gómez M
Gastroenterol Hepatol, 42(10):657-676, 23 Nov 2019
Cited by: 6 articles | PMID: 31771785
Add to export list
Erratum to «Consensus document. Management of non-alcoholic fatty liver disease (NAFLD). Clinical practice guideline» [Gastroenterol Hepatol. 2018;41(5):328-349].
Aller R, Fernández-Rodríguez C, Lo Iacono O, Bañares R, Abad J, Carrión JA, García-Monzón C, Caballería J, Berenguer M, Rodríguez-Perálvarez M, López Miranda J, Vilar-Gómez E, Crespo J, García-Cortés M, Reig M, Navarro JM, Gallego-Durán R, Genescà J, Arias-Loste MT, [...] Romero-Gómez M
Gastroenterol Hepatol, 41(7):475-476, 01 Aug 2018
Cited by: 0 articles | PMID: 29929828
Add to export list
The effects of metabolic status on non-alcoholic fatty liver disease-related outcomes, beyond the presence of obesity.
Ampuero J, Aller R, Gallego-Durán R, Banales JM, Crespo J, García-Monzón C, Pareja MJ, Vilar-Gómez E, Caballería J, Escudero-García D, Gomez-Camarero J, Calleja JL, Latorre M, Albillos A, Salmeron J, Aspichueta P, Lo Iacono O, Francés R, Benlloch S, [...] HEPAmet Registry
Aliment Pharmacol Ther, 48(11-12):1260-1270, 23 Oct 2018
Cited by: 41 articles | PMID: 30353552
Add to export list
Consensus document. Management of non-alcoholic fatty liver disease (NAFLD). Clinical practice guideline.
Aller R, Fernández-Rodríguez C, Lo Iacono O, Bañares R, Abad J, Carrión JA, García-Monzón C, Caballería J, Berenguer M, Rodríguez-Perálvarez M, Miranda JL, Vilar-Gómez E, Crespo J, García-Cortés M, Reig M, Navarro JM, Gallego R, Genescà J, Arias-Loste MT, [...] Romero-Gómez M
Gastroenterol Hepatol, 41(5):328-349, 07 Apr 2018
Cited by: 41 articles | PMID: 29631866
Add to export list
[Characteristics of Clostridium difficile infection in a high complexity hospital and report of the circulation of the NAP1/027 hypervirulent strain in Colombia].
Gualtero SM, Abril LA, Camelo N, Sanchez SD, Davila FA, Arias G, Silva E, Bustos IG, Josa DF, Torres IC, Zambrano LC, Pareja MJ
Biomedica, 37(4):466-472, 01 Dec 2017
Cited by: 6 articles | PMID: 29373767
Add to export list
Oxidized low-density lipoprotein antibodies/high-density lipoprotein cholesterol ratio is linked to advanced non-alcoholic fatty liver disease lean patients.
Ampuero J, Ranchal I, Gallego-Durán R, Pareja MJ, Del Campo JA, Pastor-Ramírez H, Rico MC, Picón R, Pastor L, García-Monzón C, Andrade R, Romero-Gómez M
J Gastroenterol Hepatol, 31(9):1611-1618, 01 Sep 2016
Cited by: 21 articles | PMID: 26946071
Add to export list
Diagnostic performance of FibroTest, SteatoTest and ActiTest in patients with NAFLD using the SAF score as histological reference.
Munteanu M, Tiniakos D, Anstee Q, Charlotte F, Marchesini G, Bugianesi E, Trauner M, Romero Gomez M, Oliveira C, Day C, Dufour JF, Bellentani S, Ngo Y, Traussnig S, Perazzo H, Deckmyn O, Bedossa P, Ratziu V, Poynard T, FLIP Consortium and the FibroFrance Group
Aliment Pharmacol Ther, 44(8):877-889, 23 Aug 2016
Cited by: 43 articles | PMID: 27549244 | PMCID: PMC5113673
Add to export list
This article is in the Europe PMC Open access subset. Refer to the copyright information in the article for licensing details.
Free full text in Europe PMC
Imaging biomarkers for steatohepatitis and fibrosis detection in non-alcoholic fatty liver disease.
Gallego-Durán R, Cerro-Salido P, Gomez-Gonzalez E, Pareja MJ, Ampuero J, Rico MC, Aznar R, Vilar-Gomez E, Bugianesi E, Crespo J, González-Sánchez FJ, Aparcero R, Moreno I, Soto S, Arias-Loste MT, Abad J, Ranchal I, Andrade RJ, Calleja JL, [...] Romero-Gómez M
Sci Rep, 6:31421, 12 Aug 2016
Cited by: 11 articles | PMID: 27514671 | PMCID: PMC4981860
Add to export list
This article is in the Europe PMC Open access subset. Refer to the copyright information in the article for licensing details.
Free full text in Europe PMC
Utility and appropriateness of the fatty liver inhibition of progression (FLIP) algorithm and steatosis, activity, and fibrosis (SAF) score in the evaluation of biopsies of nonalcoholic fatty liver disease.
Bedossa P, FLIP Pathology Consortium
Hepatology, 60(2):565-575, 26 Jun 2014
Cited by: 255 articles | PMID: 24753132
Add to export list
Cytogenetic study of a pulmonary sclerosing hemangioma.
Pareja MJ, Vargas MT, Sánchez A, Ibáñez J, González-Cámpora R
Cancer Genet Cytogenet, 195(1):80-84, 01 Nov 2009
Cited by: 3 articles | PMID: 19837274
Add to export list

1-22 of 22 results

Search life-sciences literature (45,100,050 articles, preprints and more)

Search results

Partnerships & funding